ZUBERITAMAB

UNII:	P1DFX74SQ8
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	ZUBERITAMAB
GSRS Full Record:	P1DFX74SQ8 i

2251143-19-6
GAMMA1 HEAVY CHAIN CHIMERIC (1-452) (VH (MUS MUSCULUS IGHV1-12*01(96.9%)-(IGHD)-IGHJ1*03 (100%)/HOMO SAPIENS IGHV1-46*01 (70.4%)-(IGHD)-IGHJ1*03 (85.7%)) (8.8.15) (1-122)-HOMO SAPIENSIGHG1*01 (100%) G1M17,1 (CH1 K120 (219) (123-220), HINGE 1-15 (221-235), CH2 (236-345), CH3 D12 (361), L14 (363) (346-450), CHS (451-452)) (123-452)), (225-213')-DISULFIDE WITH KAPPA LIGHT CHAIN CHIMERIC (1'-213') (V-KAPPA (MUS MUSCULUS IGKV4-72*01 (96.8%)-IGKJ1*01 (90.9 %)/HOMO SAPIENSIGKV3-11*01 (64.9%)-IGKJ2*01 (90.9%)) (5.3.9) (1'-106')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (152), V101 (190) (107'-213'))DIMER (231-231'':234-234'')-BISDISULFIDE
HS-006
HS006
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL HS006 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HS006 .KAPPA.-CHAIN, DIMER
RHCACD20MA
Zuberitamab [WHO-DD]
zuberitamab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZUBERITAMAB

Synonyms and Mappings

Resources